Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-Acetamido‑5,6‑dihydro‑4‑hydroxy‑6‑isobutoxy‑4H‑pyran‑2-carboxylic acid is a synthetic small molecule belonging to the acetamides and pyran carboxylic acids chemical classes. It has the molecular formula C12H19NO6 and a molecular weight of approximately 273.28 g/mol[1][3][7]. The compound is listed as experimental and there are no known approved therapeutic indications or established mechanisms of action in humans. Its structure features an acetamido group attached to a dihydropyran ring with hydroxy and isobutoxy substituents[1][3]. No clinical use or pharmacological activity has been reported in public databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-acetamido-5,6-dihydro-4-hydroxy-6-isobutoxy-4H-pyran-2-carboxylic acid.